MedTrace Logo

Patient Controlled Remifentanil Analgesia for Normal Labour

NCT04541719 · Status: WITHDRAWN · Phase: PHASE2 · Type: INTERVENTIONAL

Last updated 2020-09-09

No results posted yet for this study

Summary

Patient controlled remifentanil analgesia might offer comparative overall patient satisfaction and improved quality of analgesia after normal labour with continuous epidural analgesia.

Conditions

  • Labor Pain
  • Full Term Pregnancy

Interventions

DRUG

Patient-controlled remifentanil analgesia

Patient controlled remifentanil analgesia with a regimen to provide a bolus of 40 μg remifentanil with a lockout interval of 2 min

DRUG

Epidural analgesia

Patients will receive continuous epidural analgesia using bupivacaine 0.125% in conjunction with fentanyl 2 ug/ml at a rate of 8-15 ml/hr

Sponsors & Collaborators

  • Cairo University

    collaborator OTHER

  • Alexandria University

    collaborator OTHER

  • Mansoura University

    lead OTHER

Principal Investigators

  • Nabil A Abd El Raouf, MD · Professor in Cardiothoracic Ananesthesia

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
50 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-04-01
Primary Completion
2018-05-01
Completion
2018-07-01

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04541719 on ClinicalTrials.gov